Cetuximab as Second-Line Therapy in Patients with Metastatic Esophageal Adenocarcinoma: A Phase II Southwest Oncology Group Study (S0415)
2010 ◽
Vol 5
(9)
◽
pp. 1472-1476
◽
Philip J. Gold
◽
Bryan Goldman
◽
Syma Iqbal
◽
Lawrence P. Leichman
◽
Wu Zhang
◽
...
2008 ◽
Vol 26
(15_suppl)
◽
pp. 4536-4536
◽
P. J. Gold
◽
B. Goldman
◽
S. Iqbal
◽
L. P. Leichman
◽
H. J. Lenz
◽
...
2009 ◽
Vol 115
(2)
◽
pp. 285-289
◽
James V. Fiorica
◽
John A. Blessing
◽
Louis V. Puneky
◽
Angeles Alvarez Secord
◽
James S. Hoffman
◽
...
1993 ◽
Vol 15
(1)
◽
pp. 75-77
◽
J. Wendall Goodwin
◽
John Crowley
◽
Harmon J. Eyre
◽
Benjamin Stafford
◽
Kurt A. Jaeckle
◽
...
1995 ◽
Vol 76
(11)
◽
pp. 2248-2252
◽
Stanley P. Balcerzak
◽
Jacqueline Benedetti
◽
Geoffrey R. Weiss
◽
Ronald B. Natale
2006 ◽
Vol 24
(6)
◽
pp. 537-542
◽
James H. Doroshow
◽
Sheryl McCoy
◽
John S. Macdonald
◽
Brian F. Issell
◽
Taral Patel
◽
...
2007 ◽
Vol 82
(12)
◽
pp. 1056-1062
◽
Stephen H. Petersdorf
◽
Cathryn Rankin
◽
David R. Head
◽
Howard R. Terebelo
◽
Cheryl L. Willman
◽
...
1991 ◽
Vol 67
(2)
◽
pp. 363-366
◽
Louise M. Morrell
◽
Ardalan Bach
◽
Stephen P. Richman
◽
Phyllis Goodman
◽
Thomas R. Fleming
◽
...
1990 ◽
Vol 8
(1)
◽
pp. 77-80
◽
Sarah A. Taylor
◽
Thomas Fleming
◽
Daniel D. Von Hoff
◽
Joseph D. McCracken
◽
Ronald M. Bukowski
◽
...
2011 ◽
Vol 22
(12)
◽
pp. 2610-2615
◽
S. Iqbal
◽
B. Goldman
◽
C.M. Fenoglio-Preiser
◽
H.J. Lenz
◽
W. Zhang
◽
...
1992 ◽
Vol 46
(2)
◽
pp. 230-232
◽
Holly H. Gallion
◽
P.Y. Liu
◽
David E. Alberts
◽
Robert V. O'Toole
◽
Janet O'Sullivan
◽
...